Description
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
Product Unit Size | Cost | Quantity | Stock |
---|
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
Purity | ≥98% |
---|---|
Formula | C108H167N27O29 |
Formula Wt. | 2307.67 |
Synonym | HIV Endonuclease Antigenic Site; HIV Endonuclease. |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Rahman MA, Kuse N, Murakoshi H, et al. Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition. Microbes Infect. 2014 May;16(5):434-8. PMID: 24657622.
Phytoestrogen, flavonoid found in clover, soy, ...
GSK3 inhibitor.
Benzoquinone ansamycin; topoisomerase VI-B, HSP...
σ1/2and μ/κ/δ-OR agonist, α3β4/α4β2/α7...
Tenoxicam impurity
EGFR inhibitor.
Aminoglycoside; protein translation inhibitor.<...
Endogenous APP peptide cleavage product, primar...
α7 and β4 nAChR agonist, α4β2 and α6β2 nA...
Coumarin; VKORC1 inhibitor.
Glycosaminoglycan
Endogenous peptide, involved in paracrine and a...
May be useful against COVID-19
GABA analog; GABA potentiator, adenosine A1 ago...
Natriuretic, vasodilatory peptide; B1/2 agonist...
Endogenous peptide; actin polymerization inhibi...
Bisphosphonate.
IGF-1R inhibitor.
Mixture of taxanes.
Anthraquinone, Mg2+/Zn2+ chelator; bacterial DN...